期刊文献+

延缓慢性肾衰竭的治疗进展 被引量:5

Advance in therapeutic strategies to slow chronic renal failure progression
下载PDF
导出
摘要 延缓慢性肾衰竭(CRF)的进展是CRF非透析治疗中的关键环节之一,有多种机制可加速CRF最终达到终末肾的进程。临床综合性阻断相关途径对延缓CRF进展有着重要作用,主要措施包括:低蛋白饮食,阻断肾素-血管紧张素系统,控制高血压、蛋白尿、高脂血症、高凝状态,抗肾脏纤维化和慢性低氧等。更多实验研究成果的临床应用正在期待中。 Delay of the progression is one of the key points in non-dialysic treatment of chronic renal failure. The multiplicity of mechanisms could accelerate the CRF progression to end-stage renal disease. Blocking those pathways play an important role in slowing the CRF progression and the measures include low protein diet, adrenal rennin-angiotensin system (RAS) blockade, control of hypertension and hyperlipidemia, reduction of proteinuria, treatment of anti-renal fibrosis and chronic hypoxia, and anti-coagulation, etc. More renoprotective agents are being moved from hypothesis to novel therapeutics.
作者 姚勇
出处 《临床儿科杂志》 CAS CSCD 北大核心 2009年第4期310-313,325,共5页 Journal of Clinical Pediatrics
关键词 慢性肾衰竭 治疗 慢性进展 Key words: chronic renal failure treatment chronic progression
  • 相关文献

参考文献20

  • 1Ideura T, Shimazui M, Higuchi K, et al. Effect of nonsupplemented low-protein diet on very late stage CRF [J]. Am J Kidney Dis, 2003,41 (3 Suppl 1 ) : 31-34. 被引量:1
  • 2Fouque D, Wang P, Laville M, et al. Low protein diets delay end-stage renal disease in non-diabetic adults with chronic renal failure [JJ. Nephrol Dial Transplant, 2000, 15(12) : 1986-1992. 被引量:1
  • 3莫樱,陈述枚.慢性肾功能不全非透析疗法[J].中华儿科杂志,2004,42(10):747-749. 被引量:5
  • 4Fair DE, Ogborn MR, Weiler HA, et ol. Dietary soy protein attenuates renal disease progression after 1 and 3 weeks in Han:SPRD-cy weanling rats [J]. J Nutr,2004, 134(6) : 1504-1507. 被引量:1
  • 5李秀芝,孙文才,鲁玉修.低蛋白饮食合并开同对慢性肾功能衰竭的治疗[J].中国老年学杂志,2004,24(7):639-640. 被引量:5
  • 6Kopple JD, Levey AS, Green T, et all. Effect of dietary protein restriction on nutritional status in the modification of diet in renal disease study [J] . Kidney Int, 1997,52 (3) :778-791. 被引量:1
  • 7Tylicki L, Renke M, Rutkowski P, et al. Dual blockade of the renin-angiotensin-aldosterone system with high-dose angiotensin-converting enzyme inhibitor for nephroprotection: an open, controlled, randomized study [J]. Scand J Urol Nephrol,2008,13 : 1-8. 被引量:1
  • 8王小兵,王笑云,邹淑循,赵卫红,毛慧娟.氯沙坦钾对慢性肾脏病肾保护的临床初步观察[J].实用临床医药杂志,2003,7(3):266-267. 被引量:7
  • 9Kiyomoto H, Rafiq K, Mostofa M, et al. Possible underlying mechanisms responsible for aldosterone and mine-ralocorticoid receptor-dependent renal injury [J]. J Pharmacol Sci ,2008,108(4) :399-405. 被引量:1
  • 10Hernandez Prada JA, Ferreira A J, Katovich M J, et al. Structure-based identification of small molecule angiotensinconverting enzyme 2 activators as novel antihypertensive agents [ J ]. Hypertension, 2008,51 ( 5 ) : 1312-1317. 被引量:1

二级参考文献36

  • 1Toto R D, Mitchell H, McIntire D et al. Strict blood pressure control and progression of renal disease in hypertension nephrosclerosis[J]. Kidney Int. 1995, 48: 851. 被引量:1
  • 2Gansevoort R T, et al. Effects of the angiotensin Ⅱ antagonist losartan in hypertensive patients with renal disease[J]. J Hypertens. 1994, 12(supple): S37. 被引量:1
  • 3Liou H H, Huang T P, Campese V M. Effect of long-term therapy with captopril on proteinuria and renal function in patients with non-insulin-dependent diabetes with non-diabetic renal disease[J]. Nephron. 1995, 69: 41. 被引量:1
  • 4Mallion J M, Bradstreet D C, Makris L, et al. Antihypertensive efficacy and tolerability of once daily losartan potassium compared with captopril in patients with mild to moderate essential hypertension[J]. J Hypertens. 1995, 13(suppll):S35. 被引量:1
  • 5Sica D A, Lo M W, Shaw W C, et al. The pharmacokinetics of losartan in renal insufficiency[J]. J Hypertens. 1995, 13:S49. 被引量:1
  • 6Brenner BM.Hemodynamically mediated glomerular injury and the progressive nature of kidney disease[J].Kidney Int,1983;23:647-655. 被引量:1
  • 7Mitch WE.Dietary therapy in uremia:The impact on nutrition and progressive renal failure[J].Kidney Int,2000;(Suppl 75):38-43. 被引量:1
  • 8Teschan PE,Beck GJ,Dwyer IT,et al .Effect of a ketoacidaminoacid-supplemented very low protein diet on the progression of advanced renal disease:A reanalysis of the MDRD feasibility study[J].Clin Nephrol,1998;50:273-283. 被引量:1
  • 9Katsumata K, Kusano K, Hirata M, et al. Sevelamer hydrochloride prevent ectopic calcification and osteodystrophy in chronic renal failure rats. Kidney Int, 2003, 64:441-450. 被引量:1
  • 10Ferrara E, Lemire J, Reznik VM, et al. Dietary phosphorus reduction by pretreatment of human breast milk with sevelamer. Pediatr Nephrol, 2004,19:775-779. 被引量:1

共引文献36

同被引文献87

引证文献5

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部